Application
Fig1: Western blot analysis of SMARCA1 on human SMARCA1 recombinant protein using anti-SMARCA1 antibody at 1/1,000 dilution.Application
Fig2: Western blot analysis of SMARCA1 on HEK293 (1) and SMARCA1-hIgGFc transfected HEK293 (2) cell lysate using anti-SMARCA1 antibody at 1/1,000 dilution.Application
Fig3: Western blot analysis of SMARCA1 on different cell lysate using anti-SMARCA1 antibody at 1/1,000 dilution. Positive control： Lane1: PANC-1 Lane2: HEK293 Lane3: SW620 Lane4: HT-29 Lane5: SH-SY5Y Lane6: SK-OV-3Application
Fig4:Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti-SMARCA1 antibody. Counter stained with hematoxylin.Application
Fig5: Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue using anti-SMARCA1 antibody. Counter stained with hematoxylin.Application
Fig6:Flow cytometric analysis of NIH/3T3 cells with SMARCA1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Product Name | SMARCA1 [B9-H7] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ATP dependent helicase SMARCA1 antibody global transcription activator homologous sequence antibody ISWI antibody Nucleosome remodeling factor subunit SNF2L antibody NURF140 antibody Probable global transcription activator SNF2L1 antibody SMARCA1 antibody SNF2-like 1 antibody SNF2L antibody SNF2L1 antibody SNF2LB antibody SNF2LT antibody sucrose nonfermenting 2-like protein 1 antibody SWI antibody SWI/SNF related matrix associated actin dependent regulator of chromatin a1 antibody SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily a member 1 antibody SWI2 antibody |
| Product description | Energy-transducing component of NURF (nucleosome-remodeling factor) and CERF (CECR2-containing-remodeling factor) complexes. Both complexes facilitate the perturbation of chromatin structure in an ATP-dependent manner. Potentiates neurite outgrowth. May be involved in brain development by regulating En-1 and En-2 expression. May be involved in the development of luteal cells. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Host Species | Mouse |
| Tested Applications | WBIHCFC |
| WB:1:500-1:2,000 IHC:1:100-1:500 FC:1:100-1:200 |
|
| Species Reactivity | HumanMouse |
| Concentration | 2mg/ml |
| Alternative Names | ATP dependent helicase SMARCA1 antibody global transcription activator homologous sequence antibody ISWI antibody Nucleosome remodeling factor subunit SNF2L antibody NURF140 antibody Probable global transcription activator SNF2L1 antibody SMARCA1 antibody SNF2-like 1 antibody SNF2L antibody SNF2L1 antibody SNF2LB antibody SNF2LT antibody sucrose nonfermenting 2-like protein 1 antibody SWI antibody SWI/SNF related matrix associated actin dependent regulator of chromatin a1 antibody SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily a member 1 antibody SWI2 antibody |
|---|---|
| Molecular Weight(MW) | 123 kDa |
| Cellular Localization | Nucleus. |
Application
Fig1: Western blot analysis of SMARCA1 on human SMARCA1 recombinant protein using anti-SMARCA1 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of SMARCA1 on HEK293 (1) and SMARCA1-hIgGFc transfected HEK293 (2) cell lysate using anti-SMARCA1 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of SMARCA1 on different cell lysate using anti-SMARCA1 antibody at 1/1,000 dilution. Positive control： Lane1: PANC-1 Lane2: HEK293 Lane3: SW620 Lane4: HT-29 Lane5: SH-SY5Y Lane6: SK-OV-3
Application
Fig4:Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissue using anti-SMARCA1 antibody. Counter stained with hematoxylin.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human stomach cancer tissue using anti-SMARCA1 antibody. Counter stained with hematoxylin.
Application
Fig6:Flow cytometric analysis of NIH/3T3 cells with SMARCA1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Positive Control | Human SMARCA1 recombinant protein, SMARCA1-hIgGFc transfected HEK293 cell lysate, PANC-1, HEK293, SW620, HT-29, SH-SY5Y, SK-OV-3, NIH/3T3, human esophageal cancer tissue, human stomach cancer tissue. |
|---|---|
| Application Notes | WB:1:500-1:2,000 IHC:1:100-1:500 FC:1:100-1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
